CINECA IRIS Institutional Research Information System

MONTRUCCHIO, Giorgia Giuseppina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.096
AS - Asia 3.791
EU - Europa 2.907
SA - Sud America 535
AF - Africa 114
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 5
Totale 12.460
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.945
SG - Singapore 1.776
IT - Italia 1.491
CN - Cina 800
BR - Brasile 398
VN - Vietnam 338
IE - Irlanda 240
KR - Corea 199
FR - Francia 190
DE - Germania 180
HK - Hong Kong 145
IN - India 132
NL - Olanda 131
SE - Svezia 131
BD - Bangladesh 122
FI - Finlandia 115
GB - Regno Unito 99
UA - Ucraina 82
CA - Canada 67
AT - Austria 58
ID - Indonesia 52
AR - Argentina 46
IQ - Iraq 38
JP - Giappone 36
MX - Messico 35
PL - Polonia 29
RU - Federazione Russa 29
BE - Belgio 21
PK - Pakistan 21
ZA - Sudafrica 21
ES - Italia 20
VE - Venezuela 18
EG - Egitto 17
CO - Colombia 16
EC - Ecuador 15
JM - Giamaica 15
CH - Svizzera 14
CL - Cile 14
MA - Marocco 14
KE - Kenya 13
TW - Taiwan 13
NG - Nigeria 11
SA - Arabia Saudita 11
TR - Turchia 11
UY - Uruguay 11
JO - Giordania 10
LY - Libia 10
NP - Nepal 10
AU - Australia 9
GR - Grecia 9
HN - Honduras 8
PY - Paraguay 8
TH - Thailandia 8
AE - Emirati Arabi Uniti 7
CZ - Repubblica Ceca 7
IR - Iran 7
LB - Libano 7
LV - Lettonia 7
MY - Malesia 7
AZ - Azerbaigian 6
PT - Portogallo 6
CR - Costa Rica 5
LT - Lituania 5
NI - Nicaragua 5
OM - Oman 5
PE - Perù 5
PH - Filippine 5
SI - Slovenia 5
TN - Tunisia 5
UZ - Uzbekistan 5
AL - Albania 4
BO - Bolivia 4
CI - Costa d'Avorio 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
EE - Estonia 4
ET - Etiopia 4
IL - Israele 4
BG - Bulgaria 3
EU - Europa 3
HU - Ungheria 3
KZ - Kazakistan 3
LK - Sri Lanka 3
MD - Moldavia 3
PS - Palestinian Territory 3
RS - Serbia 3
AO - Angola 2
BB - Barbados 2
BY - Bielorussia 2
DK - Danimarca 2
GT - Guatemala 2
HR - Croazia 2
LU - Lussemburgo 2
MT - Malta 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
QA - Qatar 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
Totale 12.435
Salva come PNG Salva come JPEG
Città #
Singapore 1.021
San Jose 585
Santa Clara 539
Ashburn 516
Chandler 468
Dublin 236
Turin 211
Beijing 202
Seoul 191
Hefei 177
Dallas 172
Milan 139
Hong Kong 130
Fairfield 115
Lauterbourg 110
Ho Chi Minh City 95
Los Angeles 95
Columbus 94
New York 73
Nyköping 71
Buffalo 70
The Dalles 67
Torino 66
Medford 63
Bengaluru 58
Hanoi 56
Palermo 55
Rome 53
Princeton 51
Houston 50
Cambridge 47
Munich 45
Agliè 41
Boardman 41
Council Bluffs 40
Frankfurt am Main 39
Jakarta 39
São Paulo 39
Lappeenranta 38
Seattle 38
Hangzhou 37
Helsinki 37
Naples 35
Wilmington 34
Nuremberg 33
Vienna 33
Ann Arbor 28
Tokyo 28
Verona 26
Washington 26
Redondo Beach 24
Turku 23
Orem 22
Guangzhou 21
Hebei 21
Atlanta 20
Nanjing 20
Woodbridge 20
Brooklyn 19
Brussels 18
Da Nang 18
Florence 18
London 18
Toronto 18
Boston 17
Villeurbanne 17
Silver Spring 16
Warsaw 15
Chicago 14
Dong Ket 14
Johannesburg 14
Manchester 14
Montreal 14
Mumbai 14
Phoenix 14
Chennai 13
Dearborn 13
Haiphong 13
Bologna 12
Denver 12
Memphis 12
Mexico City 12
Rio de Janeiro 12
Shanghai 12
Amsterdam 11
Baghdad 11
Belo Horizonte 11
Nairobi 11
Pune 11
Abuja 10
Amman 10
Figino 10
Grugliasco 10
Pisa 10
Curitiba 9
Jacksonville 9
Montevideo 9
Redwood City 9
San Diego 9
San Francisco 9
Totale 7.266
Salva come PNG Salva come JPEG
Nome #
COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study 426
Characteristics and outcomes of COVID-19 patients admitted to hospital with and without respiratory symptoms 286
Appropriate Treatment of Invasive Candidiasis in ICU: Timing, Colonization Index, Candida Score & Biomarkers, Towards de-Escalation? 251
Antifungal Treatment Strategies in the ICU: Beyond Meta-analysis 245
Cerebrovascular Complications of COVID-19 on Venovenous Extracorporeal Membrane Oxygenation 207
Effectiveness of mid-regional pro-adrenomedullin (MR-proADM) as prognostic marker in COVID-19 critically ill patients: An observational prospective study 204
ECMO for COVID-19 patients in Europe and Israel 194
A Regional Observational Study on COVID-19-Associated Pulmonary Aspergillosis (CAPA) within Intensive Care Unit: Trying to Break the Mold 174
Anaesthesia recommendations for Alport syndrome 174
ECMO Support and Operator Safety in the Context of COVID-19 Outbreak: A Regional Center Experience 174
Putative invasive pulmonary aspergillosis within medical wards and intensive care units: a 4-year retrospective, observational, single-centre study 173
Carbapenem resistant Klebsiella pneumoniae in ICU-admitted COVID-19 Patients: Keep an eye on the ball 172
Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study 164
IMPATTO DI UNA POLITICA DI “ANTIMICROBIAL STEWARDSHIP” SU CONSUMO DI ANTIBIOTICI E RESISTENZE BATTERICHE PRESSO L’A.O.U - POLICLINICO “SAN LUIGI GONZAGA”, TORINO 161
Comparison of Copan UriSwab with BD ProbeTec urine preservative transport kit for preservation and detection of CT and NG in the ProbeTec assay 155
Continuous infusion versus intermittent administration of meropenem in critically ill patients (MERCY): A multicenter randomized double-blind trial. Rationale and design 146
First case of E. meningoseptica in Italy in a patient with necrotic hemorrhagic pancreatitis 144
Ceftazidime-Avibactam (C/A) Resistant, Meropenem Sensitive KPC-Producing Klebsiella pneumoniae in ICU Setting: We Are What We Are Treated with? 143
The Burden of Carbapenem-Resistant Acinetobacter baumannii in ICU COVID-19 Patients: A Regional Experience 143
Prognostic Value of Mid-Regional Proadrenomedullin Sampled at Presentation and after 72 Hours in Septic Patients Presenting to the Emergency Department: An Observational Two-Center Study 142
Safety profile of enhanced thromboprophylaxis strategies for critically ill COVID-19 patients during the first wave of the pandemic: observational report from 28 European intensive care units 140
Extracorporeal Membrane Oxygenation for COVID-19 respiratory distress syndrome: an Italian Society for Cardiac Surgery Report 140
Effects of steroids and tocilizumab on the immune response profile of patients with covid-19-associated ards requiring or not veno-venous extracorporeal membrane oxygenation 137
Choosing wisely: what's the actual role of antimicrobial stewardship in intensive care units? 136
Extracorporeal cardiopulmonary resuscitation (eCPR) 134
Real life Study on the Pharmacokinetic of Remdesivir in ICU patients admitted for Severe COVID-19 Pneumonia 132
Risk factors for invasive aspergillosis in ICU patients with COVID-19: current insights and new key elements 132
Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19 129
Effectiveness of mid-regional pro-adrenomedullin, compared to other biomarkers (including lymphocyte subpopulations and immunoglobulins), as a prognostic biomarker in COVID-19 critically ill patients: New evidence from a 15-month observational prospective study 128
Antimicrobial Prophylaxis in ECMO: Is the Debate Still Open? 128
Bloodstream Infections Caused by Carbapenem-Resistant Pathogens in Intensive Care Units: Risk Factors Analysis and Proposal of a Prognostic Score 124
Beneficial Effect of Prone Positioning During Venovenous Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019 124
Clinical usefulness of ELISPOT assay on pericardial fluid in a case of suspected tuberculous pericarditis 122
Are other effects of Dexmedetomidine playing a role in explaining norepinephrine requirements decrease in septic shock patients? 122
Continuous vs Intermittent Meropenem Administration in Critically Ill Patients With Sepsis: The MERCY Randomized Clinical Trial 121
Incidence, microbiology and mortality of ventilation-associated pneumonia in a large Italian cohort of critically ill patients. Results from the PROSAFE project 120
Intubation Practices and Adverse Peri-intubation Events in Critically Ill Patients from 29 Countries 120
Effectiveness of an Active and Continuous Surveillance Program for Intensive Care Units Infections Based on the EPIC III (Extended Prevalence of Infection in Intensive Care) Approach 119
Characteristics of co-infection and secondary infection amongst critically ill COVID-19 patients in the first two waves of the pandemic 115
Prevalence and risk factors for Chlamydia trachomatis infection among female medical students and women attending family planning clinics in Northern Italy 114
Early short course of neuromuscular blocking agents in patients with COVID-19 ARDS: a propensity score analysis 114
Pharmacokinetic of Cefiderocol in Critically Ill Patients Receiving Renal Replacement Therapy: A Case Series 114
Clinical and organizational factors associated with mortality during the peak of first COVID-19 wave: the global UNITE-COVID study 113
First Cases of Candida auris in a Referral Intensive Care Unit in Piedmont Region, Italy 113
Staphylococcus aureus producing Panton-Valentine Leukocidin: An emerging problem in Italian ICUs 112
Extracorporeal membrane oxygenation for COVID-19 and influenza H1N1 associated acute respiratory distress syndrome: a multicenter retrospective cohort study 112
Cefiderocol use in Gram negative infections with limited therapeutic options: Is combination therapy the key? 110
Going beyond ECMO treatment activity of a regional referral center in the context of COVID 19 pandemic 109
Oleander poisoning: an old toxic in the modern era 107
Early mobilisation in critically ill COVID-19 patients: a subanalysis of the ESICM-initiated UNITE-COVID observational study 106
Linfadenite da B. Henselae in paziente con pregressa infezione: reinfezione o riattivazione? 104
ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19. 102
Multidrug-resistant pathogens and ventilator-associated pneumonia in critically ill COVID-19 and non-COVID-19 patients: a prospective observational monocentric comparative study 102
Adjunctive immunotherapeutic agents in patients with sepsis and septic shock: a multidisciplinary consensus of 23 101
High dose esomeprazole as an anti-inflammatory agent in sepsis: Protocol for a randomized controlled trial 101
Epidemiology and Risk Factors for Nosocomial Infections in Left Ventricular Assist Device Recipients 101
At-admission prediction of mortality and pulmonary embolism in an international cohort of hospitalised patients with COVID-19 using statistical and machine learning methods 101
Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study 101
Fourier Transform Infrared Spectroscopy Application for Candida auris Outbreak Typing in a Referral Intensive Care Unit: Phylogenetic Analysis and Clustering Cut-Off Definition 99
A noma case report: A warning message from Northern Uganda 99
Association of Country Income Level With the Characteristics and Outcomes of Critically Ill Patients Hospitalized With Acute Kidney Injury and COVID-19 98
Critical and non-critical coronavirus disease 2019 patients: Which is the most predictive biomarker for disease severity and outcome? A multicentre prospective cohort study comparing mid-regional pro-adrenomedullin, inflammatory and immunological patterns 98
Pneumocystis jirovecii Pneumonia after Heart Transplantation: Two Case Reports and a Review of the Literature 98
Meropenem/Vaborbactam and Cefiderocol as Combination or Monotherapy to Treat Multi-Drug Resistant Gram-Negative Infections: A Regional Cross-Sectional Survey from Piedmont Infectious Disease Unit Network (PIDUN) 96
Liver injury in hospitalized patients with COVID-19: An International observational cohort study 96
Incidence of hospital-acquired infections due to carbapenem-resistant Enterobacterales and Pseudomonas aeruginosa in critically ill patients in Italy: a multicentre prospective cohort study 96
Trichoderma spp.-Related Pneumonia: A Case Report in Heart–Lung Transplantation Recipient and a Systematic Literature Review 94
A multi-country analysis of COVID-19 hospitalizations by vaccination status 91
Oxygenation improvement and duration of prone positioning are associated with ICU mortality in mechanically ventilated COVID-19 patients 91
In-hospital and 6-month outcomes in patients with COVID-19 supported with extracorporeal membrane oxygenation (EuroECMO-COVID): a multicentre, prospective observational study 91
Efficacy and adverse events profile of videolaryngoscopy in critically ill patients: subanalysis of the INTUBE study 90
Clinical Impact of New Delhi Metallo-Beta-Lactamase-Producing Enterobacterales in Critically Ill Patients: Are We Ready to Face the Challenge? 89
The use of Mid-Regional pro-Adrenomedullin as prognostic biomarker in ICU COVID-19 patients: preliminary data of Italian “second wave” of pandemic 89
Variability of oxygen requirements in critically ill COVID-19 patients 88
Co-infection and ICU-acquired infection in COIVD-19 ICU patients: a secondary analysis of the UNITE-COVID data set 87
SARS-CoV-2 infection and parasitic diseases: A possible role for microbiome interaction? 87
A letter to G.: When Words Are Not Enough (First Anniversary of Pandemic in the Words of a Doctor to a Patient) 87
Proadrenomedullin in the Management of COVID-19 Critically Ill Patients in Intensive Care Unit: A Systematic Review and Meta-Analysis of Evidence and Uncertainties in Existing Literature 86
Norepinephrine may improve survival of septic shock patients in a low-resource setting: a proof-of-concept study on feasibility and efficacy outside the Intensive Care Unit 86
Effect of adequacy of empirical antibiotic therapy for hospital-acquired bloodstream infections on intensive care unit patient prognosis: a causal inference approach using data from the Eurobact2 study 85
Outcomes and Impact of Pre-ECMO Clinical Course in Severe COVID-19-Related ARDS Treated with VV-ECMO: Data from an Italian Referral ECMO Center 85
Implementation of Recommendations on the Use of Corticosteroids in Severe COVID-19 84
Sugammadex-induced bronchospasm during desflurane anaesthesia: an open question 84
The value of open-source clinical science in pandemic response: lessons from ISARIC 84
Ten months of temporal variation in the clinical journey of hospitalised patients with COVID-19: An observational cohort 84
In-hospital outcomes and 6-month follow-up results of patients supported with extracorporeal membrane oxygenation for COVID-19 from the second wave to the end of the pandemic (EuroECMO-COVID): a prospective, international, multicentre, observational study. 82
Tracheostomy timing and outcome in severe covid‐19: The weantrach multicenter study 82
Impact of Multidrug-Resistant Bacteria in a Cohort of COVID-19 Critically Ill Patients: Data from a Prospective Observational Study Conducted in a High-Antimicrobial-Resistance-Prevalence Center 81
Thrombotic and hemorrhagic complications of COVID-19 in adults hospitalized in high-income countries compared with those in adults hospitalized in low- and middle-income countries in an international registry 78
Is it time for a stewardship approach to vasopressors in refractory septic shock? 78
Pirfenidone to prevent fibrosis in acute respiratory distress syndrome: The PIONEER study protocol 77
Effectiveness of Copeptin, MR-proADM and MR-proANP in Predicting Adverse Outcomes, Alone and in Combination with Traditional Severity Scores, a Secondary Analysis in COVID-19 Patients Requiring Intensive Care Admission 77
Identification of COVID-19 patients at risk of hospital admission and mortality: a European multicentre retrospective analysis of mid-regional pro-adrenomedullin 76
Major adverse cardiovascular events (MACE) in patients with severe COVID-19 registered in the ISARIC WHO clinical characterization protocol: A prospective, multinational, observational study 72
Stroke in critically ill patients with respiratory failure due to COVID-19: Disparities between low-middle and high-income countries 72
Respiratory support in patients with severe COVID-19 in the International Severe Acute Respiratory and Emerging Infection (ISARIC) COVID-19 study: a prospective, multinational, observational study 71
Choice and management of vascular access in the context of COVID-19 outbreak in Italy: Recommendations from clinical practice 69
Correction: Co-infection and ICU-acquired infection in COVID-19 ICU patients: a secondary analysis of the UNITE-COVID data set 65
Are we at a turning point for disaster medicine education? The SIAARTI Academy Critical Emergency Medicine course experience 65
Skin microbiome and placement of vascular access: A solved problem? 63
Totale 11.888
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.361
article - articoli 0
book - libri 0
conference - conferenze 2.705
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.066
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022764 49 38 41 34 41 98 30 36 15 49 172 161
2022/20231.349 110 117 49 91 120 278 131 106 156 60 75 56
2023/2024802 75 109 41 39 40 89 33 42 20 72 80 162
2024/20253.032 57 192 133 220 553 278 188 147 348 216 259 441
2025/20265.906 523 495 344 657 525 267 838 217 435 480 397 728
2026/2027175 175 0 0 0 0 0 0 0 0 0 0 0
Totale 12.865